OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud's Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness

被引：1
|
作者：
Kassamali, Bina [1 ,2 ]
Desai, Sheena [1 ,3 ]
Min, Michelle S. [1 ,2 ]
Mazori, Daniel R. [1 ,2 ]
Villa-Ruiz, Camila [1 ,4 ]
Kus, Kylee J. B. [1 ,5 ]
Cobos, Gabriela A. [1 ,2 ]
Merola, Joseph [1 ,2 ,6 ]
LaChance, Avery [1 ,2 ]
Vleugels, Ruth Ann [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Tufts Univ, Sch Med, Boston, MA USA
[4] Ponce Hlth Sci Univ, Sch Med, Ponce, Peoples R China
[5] Oakland Univ, William Beaumont Sch Med, Rochester, MI USA
[6] Brigham & Womens Hosp, Div Rheumatol, Dept Med Immunol & Allergy, Boston, MA USA
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2021年 / 20卷 / 11期
关键词：
BOTULINUM-TOXIN;
D O I：
10.36849/JDD.6135
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1257 / 1259
页数：3
相关论文
共 50 条
  • [1] Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
    Shannon Teaw
    Akash Gupta
    Alyssa Williams
    F. Perry Wilson
    Brandon J. Sumpio
    Bauer E. Sumpio
    Monique Hinchcliff
    Arthritis Research & Therapy, 25
  • [2] Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
    Teaw, Shannon
    Gupta, Akash
    Williams, Alyssa
    Wilson, F. Perry
    Sumpio, Brandon J. J.
    Sumpio, Bauer E. E.
    Hinchcliff, Monique
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [3] Item Development for the Assessment of Systemic Sclerosis-associated Raynaud's Phenomenon (ASRAP) Questionnaire
    Pauling, John
    Saketkoo, Lesley Ann
    Khanna, Dinesh
    Denton, Christopher
    Frech, Tracy
    Herrick, Ariane
    Hummers, Laura
    Shah, Ami
    Domsic, Robyn
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 819 - 822
  • [4] Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire
    Pauling, John D.
    Yu, Lan
    Frech, Tracy M.
    Herrick, Ariane L.
    Hummers, Laura K.
    Shah, Ami A.
    Denton, Christopher P.
    Saketkoo, Lesley Ann
    Withey, Jane
    Khanna, Dinesh
    Domsic, Robyn T.
    RHEUMATOLOGY, 2023, : 1281 - 1290
  • [5] RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS
    Denton, C. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 15 - 16
  • [6] Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form Development
    Yu, Lan
    Domsic, Robyn T.
    Saketkoo, Lesley-Ann
    Withey, Jane
    Frech, Tracy M.
    Herrick, Ariane L.
    Hummers, Laura K.
    Shah, Ami A.
    Denton, Christopher P.
    Khanna, Dinesh
    Pauling, John D.
    ARTHRITIS CARE & RESEARCH, 2023, : 1725 - 1734
  • [7] Raynaud's Phenomenon with Focus on Systemic Sclerosis
    Maciejewska, Magdalena
    Sikora, Mariusz
    Maciejewski, Cezary
    Alda-Malicka, Rosanna
    Czuwara, Joanna
    Rudnicka, Lidia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [8] Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon
    Marasini, B
    Casari, S
    Bestetti, A
    Maioli, C
    Cugno, M
    Zeni, S
    Turri, O
    Guagnelli, E
    Biondi, ML
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (11) : 2621 - 2623
  • [9] RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS: AN UPDATE
    Allanore, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 9 - 9
  • [10] Efficacy and Safety of Prostaglandins Analogues in Systemic Sclerosis-associated Raynaud's Phenomenon. a Systematic Review and Meta-Analysis
    Alahmari, Hana
    Jazayeri, Hila
    Johnson, Sindhu
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2995 - 2996
12345